What are the patient and physician determinants of colorectal cancer screening in Switzerland?

Détails

Ressource 1 Sous embargo indéterminé.
Accès restreint UNIL
Etat: Public
Version: Après imprimatur
Licence: Non spécifiée
ID Serval
serval:BIB_673029E70150
Type
Mémoire
Sous-type
(Mémoire de) maîtrise (master)
Collection
Publications
Institution
Titre
What are the patient and physician determinants of colorectal cancer screening in Switzerland?
Auteur⸱e⸱s
DUCKERT M.
Directeur⸱rice⸱s
COHIDON C.
Codirecteur⸱rice⸱s
SELBY K.
Détails de l'institution
Université de Lausanne, Faculté de biologie et médecine
Statut éditorial
Acceptée
Date de publication
2020
Langue
anglais
Nombre de pages
16
Résumé
Background
The colorectal cancer (CRC) is ranked third among the most common cancers in Switzerland1 and the third cancer causing the highest death rate in the world2. Early detection and treatment of CRC is associated with better prognosis and a reduction in cancer-related deaths.3
In Switzerland, two different screening tests are reimbursed by the health insurance: the colonoscopy and the FIT. These can be proposed to individuals aged between 51 and 75 years old by their general practician (GP).
This study’s objective is to analyse predictive factors, patients and GPs, of screening test among the persons screened in Switzerland.
Methods
This study is based on data collected via a survey conducted by the Policlinique Médicale Universitaire (PMU), now Unisanté, of Lausanne between August 2015 and May 2016. This survey aimed to overview the prevention in family medicine in Switzerland.
A sample of 152 GP and 1103 of their patients participated in this survey. Eligible patients were filtered by their age and whether they had been screened for CRC in the previous year.
Statistical analyses were then performed on the statistical software STATA.
Results/Discussion
On the patient’s side, education (OR= 0.16 [0.04-0.62]), information about cancer (OR = 0.29 [0.11- 0.80]) and perceived health (OR=0.98 [0.96-1.00]) are positively associated with FOBT. On the contrary, up to date vaccination (OR=3.54 [1.28-9.74]) is linked with less chance to undergo FOBT.
On the GPs side, the time spent in post-graduate formation (OR=4.27 [1.05-17.41]) was associated with less probability to undergo FOBT, whereas faecal blood test (FOBT) at the practice (OR=7.70 [1.85- 32.15]) was correlated with FOBT.
Conclusion
This study demonstrates that FOBT and colonoscopy are influenced by patient-specific and on physician-specific variables.
Awareness of the GP and knowledge of the patient are significantly associated to the screening test. GPs should be careful to the patient’s level of knowledge and add relevant information for them. To that end, good knowledge of guidelines and medical advances are required.
Mots-clé
Colorectal cancer, screening, FOBT, colonoscopy, Switzerland
Création de la notice
07/09/2021 15:04
Dernière modification de la notice
13/01/2023 7:47
Données d'usage